Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient characteristics

From: Concomitant surgical cryoablation for refractory ventricular tachycardia and left ventricular assist device placement: a dual remedy but a recipe for thrombosis?

  Patient #1 Patient #2
BASELINE
Age 70 64
Gender Female Male
Etiology of Heart Failure Non-Ischemic Ischemic
VT Characteristics Monomorphic at >188 bpm Monomorphic at 135 bpm
Type of Surgical Ablation Epicardial Endocardial Epicardial Endocardial
LVAD HeartMate II HeartMate II
LVAD Indication Destination Therapy Bridge to Transplant
POST-LVAD
Antiarrhythmic Amiodarone Amiodarone Mexiletine
Anticoagulation Heparin Warfarina Heparin Warfarina
Aspirin 81 mg 81 mg
Peak LDHb 2086 U/L 1368 U/L
Further VT No No
Thrombus Confirmed from Explanted LVAD Yes Yes
  1. aInternational normalized ratio goal 2.0-3.0
  2. bNormal lab value 124–271 U/L
  3. bpm beats per minute, LDH lactate dehydrogenase, LVAD left ventricular assist device, VT ventricular tachycardia